{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:31:32Z","timestamp":1791232292278,"version":"4.1.0"},"reference-count":38,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1912,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidem. Drug Safe."],"DOI":"10.1002\/pds.1975","type":"journal-article","created":{"date-parts":[[2010,6,7]],"date-time":"2010-06-07T06:58:28Z","timestamp":1275893908000},"page":"803-807","source":"Crossref","is-referenced-by-count":43,"title":["Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?"],"prefix":"10.1002","volume":"19","author":[{"given":"Janneke","family":"Jentink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian K.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Nijenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Wilffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lolkje T.W.","family":"de Jong-van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,6,7]]},"reference":[{"key":"10.1002\/pds.1975-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(06)68582-6","article-title":"Folic acid: a public-health challenge","volume":"367","author":"Eichholzer","year":"2006","journal-title":"Lancet"},{"key":"10.1002\/pds.1975-BIB2|cit2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1023\/A:1023385500037","article-title":"Folic acid prevents more than neural tube defects: a registry-based study in the northern Netherlands","volume":"18","author":"De Walle","year":"2003","journal-title":"Eur J Epidemiol"},{"key":"10.1002\/pds.1975-BIB3|cit3","unstructured":"Gezondheidsraad Risico's van foliumzuurverrijking (Health Council 2000 in Dutch"},{"key":"10.1002\/pds.1975-BIB4|cit4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa067103","article-title":"Reduction in neural-tube defects after folic acid fortification in Canada","volume":"357","author":"De Wals","year":"2007","journal-title":"N Engl J Med"},{"issue":"6,II","key":"10.1002\/pds.1975-BIB5|cit5","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1301\/nr.2004.jun.S35-S39","article-title":"Folic acid food fortification in Canada","volume":"62","author":"Ray","year":"2004","journal-title":"Nutr Rev"},{"key":"10.1002\/pds.1975-BIB6|cit6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/seiz.1999.0283","article-title":"Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate","volume":"8","author":"Craig","year":"1999","journal-title":"Seizure"},{"key":"10.1002\/pds.1975-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200011303432204","article-title":"Folic acid antagonists during pregnancy and the risk of birth defects","volume":"343","author":"Hernandez-Diaz","year":"2000","journal-title":"N Eng J Med"},{"key":"10.1002\/pds.1975-BIB8|cit8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1212\/01.WNL.0000044157.28073.DC","article-title":"Major malformations in offspring of women with epilepsy","volume":"60","author":"Kaaja","year":"2003","journal-title":"Neurology"},{"key":"10.1002\/pds.1975-BIB9|cit9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/jnnp.2008.156109","article-title":"Folic acid and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"80","author":"Morrow","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1002\/pds.1975-BIB10|cit10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF03082028","article-title":"De geschiedenis van de registratie en frequentiebewaking van aangeboren afwijkingen in Nederland (The history of the registry and frequency monitoring of congenital malformations in the Netherlands)","volume":"86","author":"Cornel","year":"2008","journal-title":"Tijdschr Gezondheidswet"},{"key":"10.1002\/pds.1975-BIB11|cit11","unstructured":"http:\/\/www.eurocatnederland.nl in Dutch"},{"key":"10.1002\/pds.1975-BIB12|cit12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1023\/A:1007656619529","article-title":"Additional information from parental questionnaires and pharmacy records for registration of birth defects","volume":"16","author":"Reefhuis","year":"2000","journal-title":"Eur J Epidemiol"},{"issue":"8","key":"10.1002\/pds.1975-BIB13|cit13","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S1701-2163(16)32227-7","article-title":"Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis","volume":"28","author":"Goh","year":"2006","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1002\/pds.1975-BIB14|cit14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0920-1211(01)00288-1","article-title":"Antiepileptic drugs as independent predictors of plasma total homocysteine levels","volume":"47","author":"Apeland","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1002\/pds.1975-BIB15|cit15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0022-510X(96)00256-0","article-title":"Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy","volume":"145","author":"Kishi","year":"1997","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1002\/pds.1975-BIB16|cit16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1528-1157.1999.tb00716.x","article-title":"Elevated plasma concentrations of homocysteine in antiepileptic drug treatment","volume":"43","author":"Schwaninger","year":"1999","journal-title":"Epilepsia"},{"key":"10.1002\/pds.1975-BIB17|cit17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/bdra.20318","article-title":"Plasma vitamin values and antiepileptic therapy: case reports of pregnancy outcomes affected by a neural tube defect","volume":"79","author":"Candito","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"6","key":"10.1002\/pds.1975-BIB18|cit18","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.1528-1157.2001.44300.x","article-title":"Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality","volume":"42","author":"Duncan","year":"2001","journal-title":"Epilepsia"},{"key":"10.1002\/pds.1975-BIB19|cit19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/ajmg.1320470528","article-title":"Evidence for multi-site closure of the neural tube in humans","volume":"47","author":"Van Allen","year":"1993","journal-title":"Am J Med Genet"},{"key":"10.1002\/pds.1975-BIB20|cit20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.surneu.2007.08.030","article-title":"Neural tube defects at separate sites: further evidence in support of multi-site closure of the neural tube in humans","volume":"71","author":"Ahmad","year":"2009","journal-title":"Surg Neurol"},{"key":"10.1002\/pds.1975-BIB21|cit21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1399-0004.2007.00793.x","article-title":"Toward understanding the genetic basis of neural tube defects","volume":"71","author":"Kibar","year":"2007","journal-title":"Clin Genet"},{"key":"10.1002\/pds.1975-BIB22|cit22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s004290050332","article-title":"Neural tube closure in humans initiates at multiple sites: evidence from human embryos and implications for pathogenesis of neural tube defects","volume":"201","author":"Nakatsu","year":"2000","journal-title":"Anat Embryol"},{"issue":"5","key":"10.1002\/pds.1975-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1528-1167.2009.02129.x","article-title":"Management issues for women with epilepsy-focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"key":"10.1002\/pds.1975-BIB24|cit24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0272-0590(92)90137-7","article-title":"Effect of supplementation with folic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice","volume":"18","author":"Elmazar","year":"1992","journal-title":"Fundam Appl Toxicol"},{"key":"10.1002\/pds.1975-BIB25|cit25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jn\/123.1.27","article-title":"Methionine but not folic acid or vitamin B12 alters the frequency of neural tube defects in Axd mutant mice","volume":"123","author":"Essien","year":"1993","journal-title":"J Nutr"},{"key":"10.1002\/pds.1975-BIB26|cit26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/tera.1420520506","article-title":"Effect of supplemental folic acid on valproic acid-induced embryo toxicity and tissue zinc levels in vivo","volume":"52","author":"Hansen","year":"1995","journal-title":"Teratology"},{"key":"10.1002\/pds.1975-BIB27|cit27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0024-3205(87)90562-5","article-title":"Valproic acid-induced neural tube defects: reduction by folic acid in the mouse","volume":"41","author":"Trotz","year":"1987","journal-title":"Life Sci"},{"issue":"Suppl. 5","key":"10.1002\/pds.1975-BIB28|cit28","first-page":"17","article-title":"Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis","volume":"42","author":"Wegner","year":"1992","journal-title":"Neurology"},{"key":"10.1002\/pds.1975-BIB29|cit29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/tcm.1770120503","article-title":"Methotrexate increases valproic acid-induced developmental toxicity, in particular neural tube defects in mice","volume":"12","author":"Elmazar","year":"1992","journal-title":"Teratog Carcinog Mutagen"},{"key":"10.1002\/pds.1975-BIB30|cit30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jn\/126.1.67","article-title":"Mehionine reduces the valproic acid-induced spina bifida rate in mice without altering valproic acid kinetics","volume":"126","author":"Ehlers","year":"1996","journal-title":"J Nutr"},{"key":"10.1002\/pds.1975-BIB31|cit31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ajmg.c.30051","article-title":"Mouse models of neural tube defects: investigating preventive mechanisms","volume":"135C","author":"Greene","year":"2005","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1002\/pds.1975-BIB32|cit32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0074-7742(08)00010-X","article-title":"Teratogenicity and antiepileptic drugs: potential mechanisms","volume":"83","author":"Yerby","year":"2008","journal-title":"Int Rev Neurobiol"},{"key":"10.1002\/pds.1975-BIB33|cit33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/(SICI)1520-6866(1998)18:2<49::AID-TCM1>3.0.CO;2-D","article-title":"VPA-Induced neural tube defects in mice. I. Altered metabolims of sulfur amino acids and glutathione","volume":"18","author":"Hishida","year":"1998","journal-title":"Teratog Carcinog Mutagen"},{"key":"10.1002\/pds.1975-BIB34|cit34","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1093\/jn\/132.9.2737","article-title":"Acute valproate administration impairs methionine metabolism in rats","volume":"132","author":"\u00dabeda","year":"2002","journal-title":"J Nutr"},{"key":"10.1002\/pds.1975-BIB35|cit35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.14712\/fb2007053020037","article-title":"Valproic acid, a molecular lead to multiple regulatory pathways","volume":"53","author":"Kostrouchov\u00e1","year":"2007","journal-title":"Folia Biol (Praha)"},{"issue":"5","key":"10.1002\/pds.1975-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1528-1167.2009.02130.x","article-title":"Management issues for women with epilepsy-focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast feeding","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"key":"10.1002\/pds.1975-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1002\/pds.1975-BIB38|cit38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.yebeh.2008.11.008","article-title":"The effectiveness of preconception counseling to reduce adverse pregnancy outcome in women with epilepsy: What's the evidence?","volume":"14","author":"Winterbottom","year":"2009","journal-title":"Epilepsy Behav"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.1975","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pds.1975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:28:41Z","timestamp":1740162521000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.1975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,7]]},"references-count":38,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.1002\/pds.1975","relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,7]]}}}